[Antineoplastic effect of antibiotics 3002 and 3853].
D000190:Actinomyces / Q000378:metabolism; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D001201:Ascites / Q000188:drug therapy; D001407:Bacillus / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D003470:Culture Media / Q000032:analysis; D003864:Depression, Chemical; D056890:Eukaryota / Q000187:drug effects; D007942:Leukemia, Experimental / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012510:Sarcoma 180 / Q000188:drug therapy; D012511:Sarcoma 37 / Q000188:drug therapy; D013268:Stimulation, Chemical; D013302:Streptomyces / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D003470:Culture Media
Protivoopukholevoe deĭstvie antibiotikov 3002 i 3853.